Vaccine for Shingles
Shingles is a rash caused by the virus which causes chickenpox (varicella zoster). The virus lies dormant in the spine and may be re-activated later in life. Although in the majority of people this rash is uncomfortable, it can in some (especially the more elderly) be more severe and also result in a painful and debilitating chronic pain know as Post-Herpetic Neuralgia (PHN).
1 in 4 people will have an episode of shingles in their lifetime. The incidence and severity of shingles increase with age. Up to 1 in 5 cases of shingles will develop severe and long-lasting PHN. The results of the Shingles Prevention Study, which involved more than 38,000 adults aged 60 and over showed that vaccination with Zostavax, made by Sanofi Pasteur MSD, prevented shingles by 51%; prevented shingles cases with severe pain by 73%; reduced the incidence of PHN by 67%; and reduced pain and discomfort by 61%.
The vaccine is not available on the NHS and, when it is planned for introduction in 2014, it will be limited to patients over 70 years old.
The vaccine is available from the Wellman Clinic for £180